Coloplast revenue and financials
kr 418.80Change from previous close: +2.15%Absolute change: +kr 8.80
In the fiscal year ended September 2024, Coloplast reported revenue of kr 27.03B (+10.33% year over year). Net income was kr 5.05B, a net margin of 18.7%.
Fiscal year ending in September. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +10.33%
- FY to Sep 2024 vs FY to Sep 2023
- Net income growth
- +5.62%
- FY to Sep 2024 vs FY to Sep 2023
- Net margin
- 18.7%
- FY to Sep 2023: 19.5%
Financial data
Amounts in millions of DKK; per-share values in DKK; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total assets | 46,938 | 46,649 | 48,796 | 47,880 | 49,152 |
| Current assets | 10,397 | 10,453 | 10,298 | 10,556 | 10,467 |
| Cash and equivalents | 817 | 1,067 | 1,125 | 726 | 729 |
| Inventory | 4,131 | 3,942 | 3,859 | 3,777 | 3,797 |
| Net property, plant and equipment | 8,095 | 7,688 | 7,322 | 6,840 | 6,904 |
| Long-term investments | 119 | 118 | 90.0 | 95.0 | 95.0 |
| Current liabilities | 6,660 | 5,979 | 7,928 | 10,553 | 10,967 |
| Accounts payable | 1,363 | 1,368 | 1,179 | 1,186 | 1,211 |
| Long-term debt | 20,207 | 21,340 | 20,730 | 16,564 | 16,565 |
| Total debt | 23,803 | 24,228 | 25,096 | 24,215 | 24,264 |
| Total liabilities | 33,571 | 33,806 | 34,992 | 31,432 | 32,210 |
| Total equity (incl. minority) | 13,367 | 12,843 | 13,804 | 16,448 | 16,942 |
| Retained earnings | 14,433 | 12,946 | 15,032 | 16,813 | 16,285 |